Atlas Trials

PEP-DC and OC-DC Vaccine in High Grade Serous Ovarian Carcinoma

Clinical trial NCT05714306 · WITHDRAWN

Trial details

NCT number
NCT05714306
Sponsor
Centre Hospitalier Universitaire Vaudois
Status
WITHDRAWN
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Ovarian Carcinoma
Start date
2023-08-01
Primary completion
2030-03-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.